Abstract
Excessive glucocorticoid exposure (Cushing's syndrome) results in increased adiposity associated with dysmetabolic features (including insulin resistance, hyperlipidaemia, and hypertension). Circulating cortisol levels are not elevated in idiopathic obesity, although cortisol production and clearance are increased. However, tissue glucocorticoid exposure may be altered independently of circulating levels by 11β-hydroxysteroid dehydrogenase type 1 (11HSD1), an enzyme which generates active glucocorticoid within tissues, including in adipose tissue. Transgenic overexpression of 11HSD1 in mice causes obesity. In human obesity, 11HSD1 is altered in a tissue-specific manner with reduced levels in liver but elevated levels in adipose, which may lead to glucocorticoid receptor activation and contribute to the metabolic phenotype. The reasons for altered 11HSD1 in obesity are not fully understood. Although some polymorphisms have been demonstrated in intronic and upstream regions of the HSD11B1 gene, the functional significance of these is not clear. In addition, there is mounting evidence that 11HSD1 may be dysregulated secondarily to factors that are altered in obesity, including substrates for metabolism, hormones, and inflammatory mediators. 11HSD1 is a potential therapeutic target for the treatment of the metabolic syndrome. 11HSD1 knockout mice are protected from diet-induced obesity and associated metabolic dysfunction. Although many specific inhibitors of 11HSD1 have now been developed, and published data support their efficacy in the liver to reduce glucose production, their efficacy in enhancing insulin sensitivity in adipose tissue remains uncertain. The therapeutic potential of 11HSD1 in human obesity therefore remains highly promising but as yet unproven.
Similar content being viewed by others
References
Ljung, T., Andersson, B., Bengtsson, B., Bjorntorp, P., and Marin P. (1996). Obes. Res. 4, 277–282.
Rosmond, R., Dallman, M. F., and Bjorntorp, P. (1998). J. Clin. Endocrinol. Metab. 83, 1853–1859.
Walker, B. R., Soderberg, S., Lindahl, B., and Olsson, T. (2000). J. Inter. Med. 247, 198–204.
Di Blasio, A. M., Van Rossum, E. F. C., Maestrini, S., et al. (2003). Clin. Endocrinol. (Oxf.) 59, 68–74.
Jessop, D. S., Dallman, M. F., Fleming, D., and Lightman, S. L. (2001). J. Clin. Endocrinol. Metab. 86, 4109–4114.
Ljung, T., Ottosson, M., Ahlberg, A. C., et al. (2002). J. Endocrinol. Invest. 25, 229–235.
Bjorntorp, P., Holm, G., and Rosmond, R. (1999). Diabetic Med. 16, 373–381.
Pasquali, R., Anconetani, B., Chattat, R., et al. (1996). Metab. Clin. Exp. 45, 351–356.
Vicennati, V., and Pasquali, R. (2000). J. Clin. Endocrinol. Metab. 85, 4093–4098.
Rosmond, R., Chagnon, Y. C., Holm, G., et al. (2000). Obes. Res. 8, 211–218.
Andrew, R., Phillips, D. I. W., and Walker, B. R. (1998). J. Clin. Endocrinol. Metab. 83, 1806–1809.
Fraser, R., Ingram, M. C., Anderson, N. H., Morrison, C., Davies, E., and Connell, J. M. C. (1999). Hypertension 33, 1364–1368.
Livingstone, D. E. W., McInnes, K. J., Walker, B. R., and Andrew, R. (2005). Obes. Res. 13, 1523–1526.
Rask, E., Walker, B. R., Soderberg, S., et al. (2002). J. Clin. Endocrinol. Metab. 87, 3330–3336.
Finken, M. J., Andrews, R. C., Andrew, R., and Walker, B. R. (1999). J. Clin. Endocrinol. Metab. 84, 3316–3321.
Tsilchorozidou, T., Honour, J. W., and Conway, G. S. (2003). J. Clin. Endocrinol. Metab. 88, 5907–5913.
Westerbacka, J., Yki-Jarvinen, H., and Vehkavaara, S., et al. (2003). J. Clin. Endocrinol. Metab. 88, 4924–4931.
Amelung, D., Huebner, H. J., Roka, L., and Meyerheim, G. (1953). J. Clin. Endocrinol. Metab. 13, 1125.
Tomlinson, J. W., Moore, J. S., Clark, P. M., Holder, G., Shakespeare, L., and Stewart, P. M. (2004). Endocrinology 142, 1371–1376.
Stewart, P. M. and Sheppard, M. C. (1992). Mol. Cell. Endocrinol. 83, C13-C18.
Albiston, A. L., Obeyesekere, V. R., Smith, R. E., and Krozowski, Z. S. (1994). Mol. Cell. Endocrinol. 105, R11-R17.
Dave-Sharma, S., Wilson, R. C., Harbison, M. D., et al. (1998). J. Clin. Endocrinol. Metab. 83, 2244–2254.
Mune, T., Rogerson, F. M., Nikkila, H., Agarwal, A. K., and White, P. C. (1995). Nat. Genetics 10, 394–399.
Agarwal, A. K., Monder, C., Eckstein, B., and White, P. C. (1989). J. Biol. Chem. 264, 18939–18943.
Stewart, P. M. and Krozowski, Z. S. (1994). Vitam. Horm. 57, 249–324.
Bujalska, I. J., Kumar, S., and Stewart, P. M. (1997). Lancet 349, 1210–1213.
Jamieson, P. M., Walker, B. R., Chapman, K. E., Rossiter, S., and Seckl, J. R. (2000). J. Endocrinol. 175, 685–692.
Katz, J. R., Mohamed-Ali, V., Wood, P. J., Yudkin, J. S., and Coppack, S. W. (1999). Clin. Endocrinol. 50, 63–68.
Low, S. C., Chapman, K. E., Edwards, C. R. W., and Seckl, J. R. (1994). J. Mol. Endocrinol. 13, 167–174.
Masuzaki, H., Paterson, J., Shinyama, H., et al. (2001). Science 294, 2166–2170.
Masuzaki, H., Yamamoto, H., Kenyon, C. J., et al. (2003). J. Clin. Invest. 1112, 83–90.
Kotelevtsev, Y. V., Holmes, M. C., Burchell, A., et al. (1997). Proc. Natl. Acad. Sci. USA 94, 14924–14929.
Morton, N. M., Holmes, M. C., Fievet, C., et al. (2001). J. Biol. Chem. 276, 41293–41300.
Harris, H. J., Kotelevtsev, Y. V., Mullins, J. J., Seckl, J. R., and Holmes, M. C. (2001). Endocrinology 142, 114–120.
Yau, J. L. W., Noble, J. M., Kenyon, C. J., et al. (2001). Proc. Natl. Acad. Sci. USA 98, 4716–4721.
Morton, N. M., Paterson, J. M., Masuzaki, H., et al. (2004). Diabetes 53, 931–938.
Paterson, J. M., Morton, N. M., Fievet, C., et al. (2004). Proc. Natl. Acad. Sci. USA 101, 7088–7093.
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., and Hochberg, Z. (2003). J. Clin. Endocrinol. Metab. 88, 379–384.
Rask, E., Olsson, T., Soderberg, S., et al. (2001). J. Clin. Endocrinol. Metab. 86, 1418–1421.
Stewart, P. M., Boulton, A., Kumar, S., Clark, P. M. S., and Shackleton, C. H. L. (1999). J. Clin. Endocrinol. Metab. 84, 1022–1027.
Reynolds, R. M., Walker, B. R., Phillips, D. I. W., et al. (2001). J. Clin. Endocrinol. Metab. 86, 245–250.
Andrew, R., Smith, K., Jones, G. C., and Walker, B. R. (2002). J. Clin. Endocrinol. Metab. 87, 277–285.
Sandeep, T. C., Andrew, R., Homer, N. Z., Andrews, R. C., Smith, K., and Walker, B. R. (2005). Diabetes 54, 872–879.
Livingstone, D. E. W., Jones, G. C., Smith, K., Andrew, R., Kenyon, C. J., and Walker, B. R. (2000). Endocrinology 141, 560–563.
Liu, Y., Nakagawa, Y., Wang, Y., et al. (2003). Diabetes 52, 1409–1416.
Wake, D. J., Rask, E., Livingstone, D. E., Soderberg, S., Olsson, T., and Walker, B. R. (2003). J. Clin. Endocrinol. Metab. 88, 3983–3988.
Lindsay, R. S., Wake, D. J., Nair, S., et al. (2003). J. Clin. Endocrinol. Metab. 88, 2738–2744.
Kannisto, K., Pietilainen, K. H., Ehrenborg, E., et al. (2004). J. Clin. Endocrinol. Metab. 89, 4414–4421.
Paulmyer-Lacroix, O., Boullu, S., Oliver, C., Alessi, M. C., and Grino, M. (2002). J. Clin. Endocrinol. Metab. 87, 2701–2705.
Engeli, S., Bohnke, J., Feldpausch, M., et al. (2004). Obes. Res. 12, 9–17.
Hauner, H., Schmid, P., and Pfeiffer, E. F. (1987). J. Clin. Endocrinol. Metab. 64, 832–835.
Bujalska, I. J., Kumar, S., Hewison, M., and Stewart, P. M. (1999). Endocrinology 140, 3188–3196.
Bujalska, I. J., Walker, E. A., Tomlinson, J. W., Hewison, M., and Stewart, P. M. (2002). Endocr. Res. 28, 449–461.
Basu, R., Singh, R. J., Basu, A., et al. (2004). Diabetes 53, 2051–2059.
Andrew, R., Westerbacka, J., Wahren, J., Yki-Jarvinen, H., and Walker, B. R. (2005). Diabetes 54, 1364–1370.
Basu, R., Singh, R. J., Basu, A., et al. (2005). J. Clin. Endocrinol. Metab. 90, 3919–3926.
Aldhahi, W., Mun, E., and Goldfine, A. B. (2004). Diabetologia 47, 833–836.
Phillipou, G., Palermo, M., and Shackleton, C. H. L. (1996). J. Clin. Endocrinol. Metab. 81, 3855–3860.
Jamieson, A., Wallace, A. M., Walker, B. R., et al. (1999). J. Clin. Endocrinol. Metab. 84, 3570–3574.
Draper, N., Walker, E. A., Bujalska, I. J., et al. (2003). Nat. Genet. 34, 434–439.
Millan, J. L., Botella-Carretero, J. I., Alvarez-Blasco, F., et al. (2005). J. Clin. Endocrinol. Metab. 90, 4157–4162.
Draper, N., Echwald, S. M., Lavery, G. G., et al. (2002). J. Clin. Endocrinol. Metab. 87, 4984–4990.
Nair, S., Lee, Y. H., Lindsay, R. S., et al. (2004). Diabetologia 47, 1088–1095.
Voice, M. W., Seckl, J. R., and Chapman, K. E. (1996). Gene 181, 233–235.
Williams, L. J. S., Lyons, V., MacLeod, I., et al., (2000). J. Biol. Chem. 275, 30232–30239.
Berger, J., Tanen, M., Elbrecht, A., et al. (2001). J. Biol. Chem. 276, 12629–12635.
Liu, Y. J., Nakagawa, Y., Nasuda, K., Saegusa, H., and Igarashi, Y. (1996). Life Sci. 59, 227–234.
Napolitano, A., Voice, M. W., Edwards, C. W., Seckl, J. R., and Chapman, K. E. (1998). J. Ster. Biochem. Mol. Biol. 64, 251–260.
Tomlinson, J. W., Moore, J., Cooper, M. S., et al. (2001). Endocrinology 142, 1982–1989.
Moore, J. S., Monson, J. P., Kaltsas, G., et al., (1999). J. Clin. Endocrinol. Metab. 84, 4172–4177.
Tiosano, D., Eisentein, I., Militianu, D., Chrousos, G. P., and Hochberg, Z. (2003). J. Clin. Endocrinol. Metab. 88, 379–384.
Trainer, P. J., Drake, W. M., Perry, L. A., Taylor, N. F., Besser, G. M., and Monson, J. P. (2001). J. Clin. Endocrinol. Metab. 86, 2989–2992.
Weaver, J. U., Thaventhiran, L., Noonan, K., et al., (1994). Clin. Endocrinol. (Oxf.) 41, 639–648.
Tomlinson, J. W., Crabtree, N., Clark, P. M., et al. (2003). J. Clin. Endocrinol. Metab. 88, 2113–2118.
Morton, N. M., Ramage, L., and Seckl, J. R. (2004). Endocrinology 145, 2707–2712.
Handoko, K., Yang, K., Strutt, B., Khalil, W., and Killinger, D. (2000). J. Ster. Biochem. Mol. Biol. 72, 163–168.
Stulnig, T. M., Oppermann, U., Steffensen, K. R., Schuster, G. U., and Gustafsson, J. A. (2002). Diabetes 51, 2426–2433.
Johnstone, A. M., Faber, P., Andrew, R., et al. (2004). Eur. J. Endocrinol. 150, 185–194.
Streja, D., Cressey, P., and Rabkin, S. W. (2003). J. Diabetes Complications 17, 120–127.
Ridker, P. M., Buring, J. E., Cook, N. R., and Rifai, N. (2003). Circulation 107, 391–397.
Cai, T. Q., Wong, B. M., Mundt, S. S., Thieringer, R., Wright, S. D., and Hermanowski-Vosatka, A. (2001). J. Ster. Biochem. 77, 117–122.
Cooper, M. S., Bujalska, I., Rabbitt, E., et al. (2001). J. Bone Miner. Res. 16, 1037–1044.
Sutinen, J., Kannisto, K., Korsheninnikova, E., et al. (2004). Diabetologia 47, 1668–1671.
Baker, R. W., Walker, B. R., Shaw, R. J., et al. (2000). Am. J. Respir. Crit. Care Med. 162, 1641–1647.
Widen, C., Gustafsson, J. A., and Wikstrom, A. C. (2003). Biochem. J. 373, 211–220.
Bujalska, I. J., Walker, E. A., Hewison, M., and Stewart, P. M. (2002). J. Clin. Endocrinol. Metab. 87, 1205–1210.
Banhegyi, G., Benedetti, A., Fulceri, R., and Senesi, S. (2004). J. Biol. Chem. 279, 27017–27021.
Bujalska, I. J., Draper, N., Michailidou, Z., et al. (2005). J. Mol. Endocrinol. 34, 675–684.
Atanasov, A. G., Nashev, L. G., Schweizer, R. A., Frick, C., and Odermatt, A. (2004). FEBS Lett. 571, 129–133.
Hermanowski-Vosatka, A., Gerhold, D., Mundt, S. S., et al. (2000). Biochem. Biophys. Res. Commun. 279, 330–336.
Monder, C., Stewart, P. M., Lakshmi, V., Valentino, R., Burt, D., and Edwards, C. R. W. (1989). Endocrinology 125, 1046–1053.
Hult, M., Jornvall, H., and Oppermann, U. C. (1998). FEBS Lett. 441, 25–28.
Zhang, Y.-D. and Wang, M.-S. (1997). Acta Pharmacologica Sinica 18, 240–244.
Barf, T., Vallgarda, J., Emond, R., et al. (2002). J. Med. Chem. 45, 3813–3815.
Yang, K., Khalil, M. W., Strutt, B. J., and Killinger, D. W. (1997). J. Ster. Biochem. Mol. Biol. 60, 247–253.
Li, R. S., Nakagawa, Y., Nakanishi, T., Fujisawa, Y., and Ohzeki, T. (2004). Metabolism 53, 600–606.
Livingstone, D. E. and Walker, B. R. (2003). J. Pharmacol. Exp. Therap. 305, 167–172.
Walker, B. R., Connacher, A. A., Lindsay, R. M., Webb, D. J., and Edwards, C. R. W. (1995). J. Clin. Endocrinol. Metab. 80, 3155–3159.
Andrews, R. C., Rooyackers, O., and Walker, B. R. (2003). J. Clin. Endocrinol. Metab. 88, 285–291.
Alberts, P., Engblom, L., Edling, N., et al. (2002). Diabetologia 45, 1528–1532.
Alberts, P., Nilsson, C., Selen, G., et al. (2003). Endocrinology 144, 4755–4762.
Armanini, D., Nacamulli, D., Francini-Pesenti, F., Battagin, G., Ragazzi, E., and Fiore, C. (2005). Steroids 70, 538–542.
Phillipov, G. (1998). Exp. Clin. Endocrinol. Diabetes 106, 57–60.
Tomlinson, J. W., Moore, J., Cooper, M. S., et al. (2001). Endocrinology 142, 1982–1989.
Thieringer, R., Le Grand, C. B., Carbin, L., et al. (2001). J. Immunol. 167, 30–35.
Small, G. R., Hadoke, P. W. F., Dover, A. R., Armour, D., and Walker, B. R. (2005). Proc. Natl. Acad. Sci. USA 102, 12165–12170.
Sandeep, T. C., Yau, J. L., MacLullich, A. M., et al. (2004). Proc. Natl. Acad. Sci. USA 101, 6734–6739.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Wake, D.J., Walker, B.R. Inhibition of 11β-hydroxysteroid dehydrogenase type 1 in obesity. Endocr 29, 101–108 (2006). https://doi.org/10.1385/ENDO:29:1:101
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1385/ENDO:29:1:101